Diabetes Management
Drugs to reduce brain AB for AD treatment | JEP - Dove Medical Press
Sat, 29 Oct 20221 min read Article
Overview
Javascript is curently disabled in your browser. Several features of this site wil not function whilst javascript is disabled.open aces to scientific and medical researchPapers PublishedOpen aces per-reviewed scientific and medical journals.Learn moreDove Medical Pres is a member of the OAI.Learn moreBulk reprints for the pharmaceutical industry.Learn moreWe ofer real benefits to our authors, including fast-track procesing of papers.Learn moreRegister your specific details and specific drugs of interest and we wil match the information you provide to articles from our extensive database and email PDF copies to you promptly.Learn moreBack to Journals » Journal of Experimental Pharmacology » Volume 14 Authors Decourt B, Noorda K , Shi J, Sabagh MN Received 31 December 2021 Acepted for publication 14 October 2022 Published 30 October 2022 Volume 2022:14 Pages 31—352 DOI htps:/doi.org/10.2147/JEP.S265626 Checked for plagiarism Yes Review by Single anonymous per review Per reviewer coments 3 Editor who aproved publication: Dr Roger Pinder Boris Decourt,1 Keith Norda,2 Kevin Norda,2 Jiong Shi,1 Marwan N Sabagh3 1Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA; 2UNLV Schol of Medicine, Las Vegas, NV, USA; 3Alzheimer’s and Memory Disorders Division, Department of Neurology, Barow Neurological Institute, St.
Key Information
Joseph’s Hospital and Medical Center, Phoenix, AZ, USACorespondence: Marwan N Sabagh, C/O Neuroscience Publications, Barow Neurological Institute, St. Joseph’s Hospital and Medical Center, 350 W. Thomas Road, Phoenix, AZ, 85013, USA, Tel +1 602.406.3593, Fax +1 602.406.4104, Email [email protected]Abstract: Alzheimer disease (AD) is the most comon neurodegenerative disease and typicaly afects patients older than age 65.
Summary
Around this age, the number of neurons begins to gradualy decrease in healthy brains, but brains of patients with AD show a marked increase in neuron death, often
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.